Skip to content

Clinical trials

Completed Phase 2 Pleural Effusion, Malignant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Phase: Phase 2 Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20062
20072
20081
20101
20111
20141
20151
20161
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
H. Lee Moffitt Cancer Center and Research Institute2
University of Washington2
Asan Medical Center1
Canadian Cancer Trials Group1
Eli Lilly and Company1
Haihong Yang, MD, Pricipal investigator1
Heidelberg University1
Jiangsu Simcere Pharmaceutical Co., Ltd.1
Kidney Cancer Research Bureau1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant16
Carcinoma, Non-Small-Cell Lung8
Adenocarcinoma of Lung2
Carcinoma, Ovarian Epithelial2
Fallopian Tube Neoplasms2
Pericardial Effusion2
Adenocarcinoma, Bronchiolo-Alveolar1
Brenner Tumor1
Lung Neoplasms1
Neoplasm Metastasis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.